Ikeda M, Tamada T, Takebayashi R, Okuno G, et al. Development of Fulminant Type 1 Diabetes Mellitus in the Course of Treatment with Atezolizumab for Hepatocellular Carcinoma. Intern Med 2023;62:1775-1779.
PMID: 36288990